Nathan Rich
Stock Analyst at Goldman Sachs
(1.00)
# 3,893
Out of 5,090 analysts
84
Total ratings
35.48%
Success rate
-10.16%
Average return
Main Sectors:
Stocks Rated by Nathan Rich
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| OSCR Oscar Health | Maintains: Neutral | $16 → $21 | $16.77 | +25.22% | 6 | May 9, 2024 | |
| ZTS Zoetis | Maintains: Buy | $223 → $196 | $118.65 | +65.19% | 9 | May 6, 2024 | |
| XRAY DENTSPLY SIRONA | Maintains: Neutral | $34 → $30 | $11.25 | +166.67% | 8 | May 6, 2024 | |
| AMRX Amneal Pharmaceuticals | Maintains: Buy | $6.25 → $8 | $12.18 | -34.32% | 7 | May 6, 2024 | |
| NVST Envista Holdings | Maintains: Sell | $20 → $18 | $20.23 | -13.49% | 4 | May 3, 2024 | |
| HUM Humana | Maintains: Buy | $450 → $385 | $257.85 | +49.31% | 7 | Apr 3, 2024 | |
| ELAN Elanco Animal Health | Maintains: Sell | $13 → $14 | $21.90 | -36.07% | 9 | Feb 27, 2024 | |
| TEVA Teva Pharmaceutical Industries | Maintains: Neutral | $10 → $11 | $28.46 | -61.35% | 4 | Feb 5, 2024 | |
| ALGN Align Technology | Maintains: Sell | $197 → $225 | $157.21 | +43.12% | 2 | Feb 2, 2024 | |
| IDXX IDEXX Laboratories | Maintains: Buy | $500 → $650 | $714.10 | -8.98% | 3 | Jan 17, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $100 → $88 | $75.63 | +16.36% | 9 | May 4, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $14 → $12 | $19.55 | -38.62% | 6 | Apr 19, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | $93 → $85 | $73.62 | +15.46% | 1 | Jul 21, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $10 → $11 | $10.93 | +0.64% | 3 | May 12, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $335 | $151.86 | +120.60% | 1 | Dec 14, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $535 | $330.91 | +61.68% | 5 | Dec 14, 2021 |
Oscar Health
May 9, 2024
Maintains: Neutral
Price Target: $16 → $21
Current: $16.77
Upside: +25.22%
Zoetis
May 6, 2024
Maintains: Buy
Price Target: $223 → $196
Current: $118.65
Upside: +65.19%
DENTSPLY SIRONA
May 6, 2024
Maintains: Neutral
Price Target: $34 → $30
Current: $11.25
Upside: +166.67%
Amneal Pharmaceuticals
May 6, 2024
Maintains: Buy
Price Target: $6.25 → $8
Current: $12.18
Upside: -34.32%
Envista Holdings
May 3, 2024
Maintains: Sell
Price Target: $20 → $18
Current: $20.23
Upside: -13.49%
Humana
Apr 3, 2024
Maintains: Buy
Price Target: $450 → $385
Current: $257.85
Upside: +49.31%
Elanco Animal Health
Feb 27, 2024
Maintains: Sell
Price Target: $13 → $14
Current: $21.90
Upside: -36.07%
Teva Pharmaceutical Industries
Feb 5, 2024
Maintains: Neutral
Price Target: $10 → $11
Current: $28.46
Upside: -61.35%
Align Technology
Feb 2, 2024
Maintains: Sell
Price Target: $197 → $225
Current: $157.21
Upside: +43.12%
IDEXX Laboratories
Jan 17, 2024
Maintains: Buy
Price Target: $500 → $650
Current: $714.10
Upside: -8.98%
May 4, 2023
Maintains: Buy
Price Target: $100 → $88
Current: $75.63
Upside: +16.36%
Apr 19, 2023
Maintains: Buy
Price Target: $14 → $12
Current: $19.55
Upside: -38.62%
Jul 21, 2022
Downgrades: Neutral
Price Target: $93 → $85
Current: $73.62
Upside: +15.46%
May 12, 2022
Maintains: Neutral
Price Target: $10 → $11
Current: $10.93
Upside: +0.64%
Dec 14, 2021
Initiates: Buy
Price Target: $335
Current: $151.86
Upside: +120.60%
Dec 14, 2021
Initiates: Buy
Price Target: $535
Current: $330.91
Upside: +61.68%